Care plan

The 90-day arc

Phase 3 — choosing the right next step

The most urgent open decision: what comes after residential. Here's the medical case, plainly — meant to be shared.

The starting point we all share: everyone wants Dad to come out of this healthy, grounded, and not relapsing. The only question is which kind of program gets him there safely. And for Dad, his medical situation sets a hard floor: he's on a 13-medication regimen that cannot lapse, with a cardiac history (quadruple bypass, Watchman, a ventricular-arrhythmia history) and benzodiazepine kindling vulnerability. Any program has to be able to manage all of that. That's a safety requirement, not a preference.

What the medical standard of care says

Addiction treatment follows a recognized continuum that steps down in intensity as someone stabilizes: detox → residential → partial hospitalization → intensive outpatient (IOP) → standard outpatient, with recovery support all the way through (SAMHSA, the continuum of care). After a residential program, the standard next step is at-home intensive outpatient plus a real outpatient care team — more independence, with medical and therapeutic support continuing. That is exactly Phase 3 as planned here.

Why a long faith-based residential work program is the wrong next step — for Dad

A 6-to-12-month faith-based residential work program (the Adult & Teen Challenge model is the best-known example) is not a step within that medical continuum — it sits outside it. In fairness, these programs vary, and some are licensed and do integrate medication and medical care. But the ones being considered for Dad share four features that make them a poor and genuinely risky fit for him specifically:

• No medical staff on site. His cardiac meds, blood pressure, and tics need clinical oversight. A program with no medical team simply can't provide it.
• Medication-averse. Programs that discourage or limit medication are dangerous for Dad: abruptly stopping his psychiatric meds risks a kindling cascade — a seizure-level emergency — and his cardiac medications are non-negotiable.
• Built around physical labor. "Work therapy" — building, shipping pallets, warehouse work — is not appropriate for a deconditioned 63-year-old two years out from a quadruple bypass, with chronic back pain.
• Isolating. Long stretches with no phone, no visits, mail-only contact cut him off from the care coordination and family support holding this together right now.

Going straight from a medical residential program into a no-medical-staff, medication-averse work program is a step out of the standard of care, not forward in it. For someone with Dad's medical complexity, that is a real safety risk.

Faith and medical care aren't either/or

This isn't faith versus medicine, and it shouldn't be. Dad genuinely wants a faith-based path — that's a good and grounding thing. It just doesn't have to mean a year living away in a program with no medical support. A non-residential faith track — a healing school, Bible study, a church discipleship program, a strong recovery fellowship — can layer right on top of at-home IOP and his medical team. He gets the spiritual grounding and stays medically safe. The honest test for any program is three plain questions: Does it have medical staff? Can it manage his medications? Can it safely care for a cardiac + kindling patient? If yes, it's worth a serious look. If no, it isn't safe for him — however good it might be for someone healthier.

Source: SAMHSA — Intensive Outpatient Treatment and the Continuum of Care. A lay summary for the family, not medical advice.

What we're pushing the care team on

Priority-ordered, most urgent first. These fit Dad's specific profile and the 2026 standard of care — not all need to land now; many are for the Phase 3 outpatient team. Resolved items are greyed at the bottom.

1. Neurologist consult for Tourette's. His worst-felt symptom, now causing self-injury (raw tongue). TRT has no in-house neuro, so it's an outside referral — a movement-disorder specialist who takes his insurance. Start now, don't wait for Phase 3. Neuro-visit prep →
2. Kindling prophylaxis. No anticonvulsant (gabapentin / pregabalin / levetiracetam) in the regimen yet, despite being flagged 4+ sessions — the load-bearing safety ask. See the Kindling explainer below.
3. NAC dose escalation. He's on 300 mg/day; the research dose for tics + craving is meaningfully higher (600–1200 mg BID). Easy ask, and it supports the tic picture above.
4. Vascepa (icosapent ethyl). OmegaCheck 3.0% (high SCD risk), TG 237, established CAD — the REDUCE-IT profile exactly. A real Rx (~25% CV event reduction), not "more fish oil." For cardiology. labs →
5. Continuous glucose monitor. Dexcom Stelo / Libre Lingo (OTC, ~$80/mo) on top of baseline insulin 57 + olanzapine — catches glucose excursions before A1c reflects them. Standard for atypical-antipsychotic monitoring.
6. Long-acting naltrexone (Vivitrol). Monthly injection, gold-standard relapse prevention for opioid + alcohol. Should be on the table before IOP starts.
7. Lp(a). One-time inherited CAD marker, missing from the 2025 baseline. Worth knowing for the cardio handoff. labs →
8. DEXA scan. Bone-density baseline — long Xanax history + new PPI + low DHEA + fall risk is a real osteoporosis vector. Get it before Phase 3.
9. Ketamine / esketamine (Spravato). If duloxetine doesn't land in 6–8 weeks. FDA-approved for treatment-resistant depression; raise at the Phase 2 review.
10. GLP-1 (Ozempic / Mounjaro family). Metabolic rescue if olanzapine worsens his markers — could keep him on the antipsychotic without the metabolic damage.
11. HRV wearable (Whoop / Apple Watch). Objective read on kindling sensitivity over time — tracks recovery in a way self-report can't. Cheap insurance.
12. Antidepressant PGx (GeneSight) — back + interpreted. Drawn 6/8; CYP2D6 intermediate → duloxetine runs high (don't escalate; lower or switch). full read →
13. Plavix responder (CYP2C19) — answered by GeneSight. He's an ultrarapid metabolizer → clopidogrel activates well; not a non-responder. full read →

Kindling — the load-bearing concept

Kindling is progressive neurological sensitization from repeated benzo/sedative withdrawal cycles. Each subsequent withdrawal is worse than the last — the GABA/glutamate balance keeps getting more dysregulated. Originally a 1960s epilepsy term (small repeated electrical pulses eventually trigger full seizures); applied to addiction medicine since the 1980s.

Why it matters for Dad: ~30 years of daily Xanax + at least one cold-turkey event (4/9/2026) = his CNS is now kindling-vulnerable. If he ever has another abrupt withdrawal — even from a missed pharmacy refill — the trajectory escalates: tremor → autonomic instability → seizure → status epilepticus → death. Each event lowers the threshold further.

Mitigations

• Anticonvulsant prophylaxis during any future taper (gabapentin, pregabalin, levetiracetam, oxcarbazepine, lamotrigine)
• Slow long-acting benzo taper instead of fast cessation, if ever needed again
• Never abrupt discontinuation — never let any psych med run out
• Long-term avoidance of GABA-suppressive substances (alcohol especially)
• HRV / autonomic wearable as early-warning signal

Specific asks for Dr. Ignatov / Lynn

1. What's the kindling-risk assessment on file? It should be documented prominently.
2. Is gabapentin (or pregabalin, levetiracetam, oxcarbazepine, lamotrigine) being considered for kindling prophylaxis? Right now: none in regimen.
3. What's the discharge plan around never-cold-turkey-again? Stepmom needs explicit education.
4. Is the kindling vulnerability flagged prominently for any future ER visit?
5. If a future taper is ever needed, what's the protocol? Slow, long-acting benzo, anticonvulsant cover.